GLF
BLUE

Groupe la Francaise’s bluebird bio BLUE Stock Holding History

Groupe la Francaise’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-135,000
Closed -$679K – 454
2025
Q1 		$679K Buy
+135,000
New +$812K 0.01% 274

Other funds holding BLUE

Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Groupe la Francaise's BLUE Position: Q2 2025 in Review

Groupe la Francaise sold out of bluebird bio (BLUE) in Q2 2025, closing a stake of 135,000 shares — an estimated $679K sold.

Groupe la Francaise first reported a position in BLUE in Q1 2025 and held it in 1 quarter. The position peaked at $679K in Q1 2025. 3 funds tracked by Wall St. Rank hold BLUE as of Q2 2025.

  • Groupe la Francaise reported no remaining bluebird bio position as of Q2 2025 after selling out during the quarter.
  • Groupe la Francaise sold 135,000 bluebird bio shares in Q2 2025, an estimated $679K.
  • Groupe la Francaise first reported a position in bluebird bio in Q1 2025 and held it in 1 quarter.
  • Groupe la Francaise's bluebird bio position peaked at $679K in Q1 2025.
  • 3 funds tracked by Wall St. Rank held bluebird bio as of Q2 2025.

Based on Groupe la Francaise's 13F filing for Q2 2025, filed 13 Aug 2025.